Oncopeptides AB (publ) (STO:ONCO)
Sweden · Delayed Price · Currency is SEK 6.03
+0.44 (7.87%)
Oct 31, 2025, 12:59 PM CET
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of 1.65 billion as of October 31, 2025. Its market cap has increased by 266.12% in one year.
Market Cap
1.65B
Enterprise Value
1.71B
Revenue
50.87M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.03
Market Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 1.67B to 1.65B, a decrease of -1.38%. That is a compound annual growth rate of -0.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 1.65B | 391.76% |
| Dec 30, 2024 | 334.83M | -53.79% |
| Dec 29, 2023 | 724.64M | -36.76% |
| Dec 30, 2022 | 1.15B | 81.18% |
| Dec 30, 2021 | 632.45M | -94.51% |
| Dec 30, 2020 | 11.53B | 63.96% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 112.77B |
| Getinge AB | 60.82B |
| Sectra AB | 58.15B |
| Medicover AB | 39.10B |
| Camurus AB | 37.23B |
| Asker Healthcare Group AB | 33.00B |
| BioArctic AB | 25.95B |
| AddLife AB | 25.03B |